Yao; Xiao Jun
Patent Applications and Registrations
Patent applications and USPTO patent grants for Yao; Xiao Jun.The latest application filed is for "methods of treating cancer".
- Yao; Xiao Jun - Taipa MO
- Yao; Xiao Jun - Macau CN
- Yao; Xiao Jun - MO MO
| Patent | Date |
|---|---|
| Method of identifying a gene associated with a disease or pathological condition of the disease Grant 10,787,708 - Liu , et al. September 29, 2 | 2020-09-29 |
| Methods of treating cancer Grant 10,702,500 - Yao , et al. | 2020-07-07 |
| Methods For Treating Cancer App 20190175526 - YAO; Xiao Jun ; et al. | 2019-06-13 |
| Methods Of Treating Cancer App 20190175553 - YAO; Xiao Jun ; et al. | 2019-06-13 |
| Methods of treating cancer Grant 10,278,955 - Yao , et al. | 2019-05-07 |
| Methods of treating cancer Grant 10,208,028 - Leung , et al. Feb | 2019-02-19 |
| Method Of Identifying A Gene Associated With A Disease Or Pathological Condition Of The Disease App 20190017116 - Liu; Liang ; et al. | 2019-01-17 |
| Lignanamides and a method of treating neurodegenerative diseases by using the same Grant 10,155,721 - Zhu , et al. Dec | 2018-12-18 |
| Bufadienolide For Treatment Of Non-small Cell Lung Cancer App 20180348222 - Liu; Liang ; et al. | 2018-12-06 |
| ALK Kinase Inhibitor and its use Grant 10,111,876 - Yao , et al. October 30, 2 | 2018-10-30 |
| Novel Lignanamides And A Method Of Treating Neurodegenerative Diseases By Using The Same App 20180305300 - ZHU; Guo-Yuan ; et al. | 2018-10-25 |
| ROS1 inhibitor and its use Grant 9,962,378 - Yao , et al. May 8, 2 | 2018-05-08 |
| Alk Kinase Inhibitor And Its Use App 20180050037 - Yao; Xiao-Jun ; et al. | 2018-02-22 |
| Method of treating lung cancer Grant 9,884,047 - Yao , et al. February 6, 2 | 2018-02-06 |
| Method of treating lung cancer Grant 9,884,046 - Yao , et al. February 6, 2 | 2018-02-06 |
| Combination treatment of RAS-positive diseases with PDE-.delta. inhibitor and direct autophagy inhibitor Grant 9,861,623 - Liu , et al. January 9, 2 | 2018-01-09 |
| Method to treat lung cancer Grant 9,855,250 - Liu , et al. January 2, 2 | 2018-01-02 |
| Use of tangeretin in cancer treatment Grant 9,808,439 - Ma , et al. November 7, 2 | 2017-11-07 |
| Use of nobiletin in cancer treatment Grant 9,808,477 - Ma , et al. November 7, 2 | 2017-11-07 |
| Oncogenic ROS1 and ALK kinase inhibitor Grant 9,782,400 - Yao , et al. October 10, 2 | 2017-10-10 |
| Methods for treating lung cancer Grant 9,744,145 - Liu , et al. August 29, 2 | 2017-08-29 |
| Use Of Nobiletin In Cancer Treatment App 20170143668 - MA; Wen-zhe ; et al. | 2017-05-25 |
| Pde-delta Inhibitor For The Treatment Of Cancer App 20170135979 - Yao; Xiao Jun ; et al. | 2017-05-18 |
| Novel Ros1 Inhibitor And Its Use App 20170079972 - Yao; Xiao Jun ; et al. | 2017-03-23 |
| Use Of Tangeretin In Cancer Treatment App 20170027900 - MA; Wen-zhe ; et al. | 2017-02-02 |
| Use Of Nobiletin In Cancer Treatment App 20170027901 - MA; Wen-zhe ; et al. | 2017-02-02 |
| Oncogenic ROS1 kinase inhibitor Grant 9,526,722 - Yao , et al. December 27, 2 | 2016-12-27 |
| Oncogenic Ros1 And Alk Kinase Inhibitor App 20160367547 - Yao; Xiao Jun ; et al. | 2016-12-22 |
| Oncogenic Ros1 Kinase Inhibitor App 20160367546 - YAO; Xiao Jun ; et al. | 2016-12-22 |
| Method of treating cancer Grant 9,522,125 - Yao , et al. December 20, 2 | 2016-12-20 |
| Identification of a new AMPK activator for treatment of lung cancer Grant 9,364,469 - Leung , et al. June 14, 2 | 2016-06-14 |
| N-desmethyldauricine, A Novel Autophagic Enhancer for Treatment of Cancers and Neurodegenerative Conditions Thereof App 20150133492 - WONG; Kam Wai ; et al. | 2015-05-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 